Bacterial and Viral Specimen Collection Market By Product (Bacterial Specimen Collection, and Viral Specimen Collection), By Application, By End User - Global Industry Outlook, Key Companies (Puritan Medical Products, COPAN Diagnostics, Becton, Dickinson and Company, and others), Trends and Forecast 2024-2033

The bacterial and viral specimen collection market has expanded tremendously at the global level due to the growing rate of infectious diseases and the need for proper diagnosis. Collection swabs, transport media packets, and blood sampling sets are some of the critical items used in the isolation and identification of bacteria as well as viruses. The market has been categorized into bacterial and viral specimen collection; the bacterial part takes up more of the market due to its uses in many areas such as medicine and research.

With the existing and developing diagnostic techniques, coupled with recent passed global health crises, the need for proper collection methods has significantly increased. Players such as Thermo Fisher Scientific and Becton, Dickinson, and Company are heavily invested in their research and development activities to introduce new as well as diversify their products. These aspects affect market dynamics, with the growing use of point-of-care testing and given heightened understanding of the necessity of early detection of diseases.

The US Bacterial and Viral Specimen Collection Market

The US bacterial and viral specimen collection market is projected to be valued at USD 3.7 billion in 2024. It is expected to witness subsequent growth in the upcoming period as it holds USD 7.3 billion in 2033 at a CAGR of 8.0%.

The US bacterial and viral specimen collection market is a significant segment of the global market, driven by high healthcare expenditure and advanced healthcare infrastructure. It is most likely that the rising incidence of infectious diseases and the requirement for accurate diagnosis in short duration will fuel the market.

• The growth of this industry in the US is also supported by the increasing focus on point-of-care testing and home diagnostics. The market report specifies that the growth rate is quite high during the forecast period, driven mainly by developments made in the transport media and blood collection kits segments.
• As the US healthcare system continues to give more importance to diagnostic accuracy and efficiency, until at least the end of the forecast period, the specimen collection market is bound to register growth, thereby cementing its position as a key player in the global market. The bacterial specimen collection segment holds a larger share of the market due to several factors.

Key Takeaways

• Market Value: The global bacterial and viral specimen collection market size is estimated to have a value of USD 9.7 billion in 2024 and is expected to reach USD 20.2 billion by the end of 2033.
• The US Market Size: The US bacterial and viral specimen collection market is projected to be valued at USD 3.7 billion in 2024 at a CAGR of 8.0%.
• Global Growth Rate: The market is growing at a CAGR of 8.5 percent over the forecasted period.
• By Product Segment Analysis: Bacterial specimen collection is projected to dominate the product segment in this market as it will hold 64.1% of the market share by the end of 2024.
• By Application Segment Analysis: In terms of application, diagnostics are anticipated to dominate the application segment as it holds 66.1% of the market share in 2024.
• By End User Segment Analysis: Hospitals and clinics are expected to dominate the end-user segment in this market as they hold the highest market share by the end of 2024.
• Regional Analysis: North America is expected to have the largest market share in the global bacterial and viral specimen collection market with a share of about 45.1% in 2024.

Use Cases

• Routine Diagnostic Testing: Ensuring correct and timely detection of bacterial and viral infections by hygienic reliable specimen collection method.
• Epidemiological Studies: Collecting specimens to study the prevalence and spread of infectious diseases, assisting in public health interventions.
• Vaccine Development: Gathering samples to isolate pathogens and understand their characteristics, is crucial for developing effective vaccines for various chronic diseases.
• Point-of-Care Testing: Facilitating instant diagnosis and treatment decisions in scientific settings through efficient specimen collection.
• Drug Development: Utilizing collected specimens to identify and test new therapeutic agents against bacterial and viral infections.

Market Dynamic

Trends

Rising Cases of Infectious Diseases
One of the major factors boosting demand for bacterial and viral specimen collection products is the rise in the occurrence of bacterial and viral infections across the world. This rise in infections presents an opportunity for the segment to focus on effective and reliable techniques of specimen collection that would help in diagnosis and treatment. This further extends and aids the market growth for bacterial and viral specimen collection products during the forecast period as cases of infectious diseases like COVID-19, influenza, and bacterial infections are constantly increasing.

Technological Advancements in Specimen Collection
Innovations in specimen collection products and techniques are powering the market dynamics. The invention of automated specimen collection systems, advanced swabs, transport media, etc. can improve the efficiency and accuracy of sample collection and processing to a large extent. These, in turn, raise the bar in terms of the reliability of diagnostic outcomes and thereby act as drivers for the bacterial and viral specimen collection market. Thermo Fisher Scientific and Becton, Dickinson, and Company lead the inning about such technological innovations, thus being responsible for considerable market growth.

Growth Drivers

Increased Healthcare Expenditure
It is expected that the bacterial and viral specimen collection market will grow due to increased spending on healthcare in developed and emerging economies. Greater expenditure on healthcare budgets facilitates the adoption of advanced specimen collection kits and transport media, thus fostering better diagnostic capabilities. Such investments in healthcare infrastructure, therefore, provide the necessary support for the growth of the market through the presence and ease of use of quality specimen collection products during this period.

Government Initiatives and Public Health Programs
Government initiatives and public healthcare programs control infectious diseases, which in turn propel market growth. Such programs emphasize the requirement for early diagnosis and treatment, thereby increasing the adoption of bacterial and viral specimen collection products. The regulatory frameworks and quality standards that health authorities provide give support to the growth of the market by making sure that specimen collection kits and transport media are safe and effective.

Growth Opportunities

Growth in Emerging Markets
It is expected that the market for bacterial and viral specimen collection will have immense opportunities in developing economies. A focus on investing in healthcare infrastructure and diagnostic facilities is observed in countries like Asia-Pacific, Latin America, and Africa. This extending market, combined with rising awareness about infectious diseases, will increase demand for reliable and efficient products associated with specimen collection to aid diagnosis, thereby driving growth prospects through 2024.

Advanced Development of Specimen Collection Products
Advanced specimen collection products have huge growth opportunities in the market. Fast-changing specimen collection techniques and transport media will increase the accuracy and reliability of diagnostic testing. Companies involved in research and development to introduce new products like automated specimen collection systems and specialized transport medial are likely to attain a competitive edge, thus driving the growth of the market.

Restraints

High Cost of Advanced Specimen Collection Products
Advanced specimen collection products are exorbitantly priced, offering major restraint in this market. The products come with more efficiency and accuracy, but mostly the prices are steep; their diffusion can easily remain limited, especially in resource-limited settings. This cost barrier affects the overall market growth, particularly in emerging economies where healthcare budgets remain constrained and affordability is a paramount matter.

Regulatory Challenges and Compliance Issues
Challenges and Issues in Compliance with the Regulations One of the major growth restraints in the bacterial and viral specimen collection market is regulatory challenges and compliance issues. Once the regulatory requirement for the stringent approval and commercialization of specimen collection products is strategically established, product development costs will surge, leading to delays in market entry. The complexity is also increased by the need to comply with various regulatory requirements in different regions themselves, which might further change the dynamics of the market and lower the growth rate of the bacterial and viral specimen collection market during the forecast period.

Research Scope and Analysis

By Product

In the context of the product, bacterial specimen collection is projected to dominate this segment as it will hold 64.1% of the market share by the end of 2024. The high prevalence of bacterial infections, such as tuberculosis and pneumonia, necessitates sepsis and requires a reliable means of specimen collection for identification and treatment. Swabs, examples of which are nasal, throat, and rectal swabs, are seen everywhere in the collection of bacterial specimens because they are versatile and easy to use. Bacterial transport media, available in liquid, solid, and semi-solid forms, help to ensure specimen vitality and integrity through transportation to the laboratories and are consequently critical elements of diagnosis accuracy. 

Blood collection kits add to the dominance of bacterial specimen collection as they are key for diagnosis related to bloodstream infections. Apart from these, other consumables such as urine collection kits and sputum collection kits are also providing end-to-end solutions for many bacterial infections. The continued research and development in the domain of better diagnosis methodologies boost the demand further. Players operating in this market keep innovating and making bacterial specimen collection techniques ever more efficient and reliable. The growing need for accurate diagnosis and successful treatment against bacterial infection shall further support the supremacy of bacterial specimen collection in the market.

By Application

In terms of application, diagnostics are anticipated to dominate the application segment as it holds 66.1% of the market share in 2024. Diagnostics dominate the bacterial and viral specimen collection market segment since it is of paramount importance in disease management. Routine diagnostic testing is done in every face of bacterial and viral identification processes to ensure timely treatment, forestall the spread of a disease, or ensure negative test results. Point-of-care testing gives prompt diagnoses, which afford better treatment for patients while easing the workload of health facilities. Specific diagnostic testing can recognize the specific pathogen that enables targeted treatment strategies. 

Increasing infectious diseases and an integral part of rapid, accurate diagnosis create huge potential demand in diagnostic testing. Research activities are high, but their major application is in the development of diagnostic tools and therapeutics. Clinical research studies in this sense may include epidemiological studies, vaccines, and drug development. Each of these modes requires accurate diagnostic methods for data collection and analysis. However, the main usage lies in the diagnosis itself. A market report says high demand for diagnostic testing products, such as swabs, transport media, and blood collection kits, underlines the dominance of diagnostics in the specimen collection market during the forecast period.

By End User

Hospitals and clinics are expected to dominate the end-user segment in this market as they hold the highest market share by the end of 2024. A few critical factors keep the hospitals and clinics segment at the top in terms of bacterial and viral specimen collection. For example, they are primary facilities for treating most infectious diseases and require a high degree of extensive and reliable specimen collection capabilities within them. The increasing prevalence of bacterial and viral infections presents an uncontested opportunity for the clinical setting and hence drives demand for products related to bacterial and viral specimen collection, like swabs, transport media, and blood collection kits. Accurate and prompt diagnosis is mostly the concern of hospitals and clinics, to provide the right therapy protocols further underlining a requirement that cannot be dispensed with for dependable specimen collection techniques.

Moreover, these have infrastructure and human resources to collect and process specimens. The centers can maintain sterility, properly store all specimens, and ensure timely transportation of specimens to the diagnostic laboratories. This is very well reflected in the global bacterial and viral specimen collection market report through the huge share held by hospitals and clinics, thereby showcasing their important role in infectious disease management.

Development of diagnostic technologies and increasing awareness about early disease detection are some of the factors augmenting specimen collection market size and leading to growth in hospitals. With a rise in demand for bacterial and viral specimen collection products, hospitals and clinics continue to remain one of the largest market share holders in this segment, thus driving the growth of the market during the forecast period.

The Bacterial and Viral Specimen Collection Market Report is segmented based on the following

By Product

• Bacterial Specimen Collection
• Swabs
• Nasal Swabs
• Throat Swabs
• Rectal Swabs
• Other Swabs
• Bacterial Transport Media
• Liquid Media
• Solid Media
• Semi-solid Media
• Blood Collection Kits
• Other Consumables
• Viral Specimen Collection
• Swabs
• Nasopharyngeal Swabs
• Oropharyngeal Swabs
• Other Swabs
• Viral Transport Media
• Universal Transport Media (UTM)
• Specific Viral Transport Media
• Blood Collection Kits
• Serum Collection Kits
• Plasma Collection Kits
• Other Consumables

By Application

• Diagnostics
• Routine Diagnostic Testing
• Point-of-Care Testing
• Specialized Diagnostic Testing
• Research
• Clinical Research
• Epidemiological Studies
• Vaccine Development
• Drug Development

By End User

• Hospitals & Clinics
• Home Test
• Research Laboratories

Regional Analysis

North America is projected to dominate the global bacterial and viral specimen collection market as it will hold 45.1% of the market share in 2024. North America, according to several key factors, is dominating the bacterial and viral specimen collection market. Well-developed infrastructure in the healthcare sector along with a high spending level on healthcare support the wide adoption of specimen collection products and techniques across the region. 

The burden of bacterial and viral infections in North America requires efficient and reliable specimen collection, which drives demand for bacterial and viral specimen collection products. The presence of major market participants, including Thermo Fisher Scientific and Becton, Dickinson, and Company, further cements North America's leadership position in the global bacterial and viral specimen collection market. Such companies invest heavily in research and development, continuously innovating new specimen collection products and techniques that accelerate the growth of the concerned market.

The existence of a strong local regulatory framework ensures quality and safety in specimen collection products and consequently makes healthcare providers and patients confident in using them. This again accelerates the demand for bacterial and viral specimen collection since people understand a lot about the early diagnosis and treatment of infectious diseases in North America.

Furthermore, the region benefits from a properly developed network of distribution and objection facilities with advanced laboratories that are suitable for quick processing and analysis of collected specimens. This thus contributes to forming the basis of reliable and timely diagnosis for bacterial and viral infections, thereby driving the growth rate of the bacterial and viral specimen collection market during the forecast period.

Competitive Landscape

The global bacterial and viral specimen collection market consists of various key players. Innovation, market growth, and high-paced market leadership are provided by major companies such as Thermo Fisher Scientific, Becton, Dickinson and Company, and Longhorn Vaccines and Diagnostics. The specimen collection product array for these companies ranges from swabs and transport media to blood collection kits, catering to end-users such as hospitals, clinics, and research laboratories.

Market competitiveness is on the rise, as companies develop products and strategic collaborations to buy out other firms for a great market share. For instance, high-end specimen collection kits developed with transport media from Thermo Fisher Scientific have captured considerable market share due to their reliability and effectiveness in maintaining specimen integrity.

Apart from these companies, regional companies also influence the competitive landscape by serving regionally specific markets and niches. These companies enhance the growth of the bacterial and viral specimen collection market through regional requirements and concerned regulations. Another driver for the market is the increasing demand for effective and safe specimen collection products as a result of the spread of bacterial and viral infections across the world.

Some of the prominent players in the Global Bacterial and Viral Specimen Collection Market are

• Puritan Medical Products
• COPAN Diagnostics
• Becton, Dickinson and Company
• Thermo Fisher Scientific, Inc.
• Quidel Corporation
• Longhorn Vaccines and Diagnostics, LLC
• Premium Packaging
• Trinity Biotech
• Medical Wire & Equipment
• HiMedia Laboratories
• Hardy Diagnostics
• Nest Scientific
• VIRCELL S.L.
• Other Key Players

Recent Developments

June 2024

• Thermo Fisher Scientific launched an advanced swab and transport media kit designed for rapid viral specimen collection and preservation. This new product aims to improve the efficiency of specimen collection and ensure higher accuracy in diagnostic testing, addressing the increasing demand for reliable and quick diagnostic solutions in the viral specimen collection market.

May 2024

• Becton, Dickinson, and Company introduced a new line of blood collection kits tailored for improved safety and efficiency in clinical settings. These kits are designed to minimize contamination risks and enhance the ease of blood sample collection, thereby supporting the growing needs of hospitals and clinics for effective specimen collection products.

April 2024

• Longhorn Vaccines and Diagnostics expanded its product portfolio with innovative bacterial transport media, enhancing specimen stability for extended periods. This development is particularly significant for remote and resource-limited settings, where preserving specimen integrity during transport is critical for accurate diagnostic outcomes.

March 2024

• Puritan Medical Products announced a strategic partnership with major hospitals to supply specialized swabs for routine diagnostic testing. This collaboration aims to ensure a steady supply of high-quality specimen collection products to healthcare providers, supporting the routine and specialized diagnostic needs of hospitals.

February 2024

• Copan Diagnostics unveiled an automated specimen collection system aimed at streamlining sample collection processes in high-volume laboratories. This system is designed to increase the efficiency and accuracy of specimen collection, reducing human error and enhancing the throughput of diagnostic laboratories.

January 2024

• Medline Industries launched a comprehensive training program for healthcare professionals on best practices in specimen collection and transport. This initiative aims to improve the competency of healthcare workers in handling and transporting specimens, ensuring the reliability of diagnostic results.

December 2023

• Hardy Diagnostics introduced a new range of semi-solid bacterial transport media, improving specimen viability during extended transportation. This product is particularly beneficial for situations where immediate specimen processing is not feasible, ensuring that samples remain viable for accurate diagnosis.

November 2023

• Roche Diagnostics released a state-of-the-art viral transport media specifically designed for the rapid and reliable transport of viral specimens. This media enhances the stability of viral samples, facilitating accurate and timely diagnostic testing in various healthcare settings.